InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (13 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
13
T+90 hit rate
100%
T+90 mean return
+20.5%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by FARRELL PETER C, Director. Insider active across 3 companies, notably RESMED INC. Aggregated, 33 reports have been published. Breakdown: 1 buy · 13 sells. Total volume traded: €8.8m. History available since 13 August 2021. The latest transaction was filed on 7 May 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations33 total
2,000 shares@ US$242.254.7% of flowResMed Common StockSEC:0001127602-25-013743:0
2,000 shares@ US$219.744.5% of flowResMed Common StockSEC:0001127602-25-011625:0
2,000 shares@ US$227.714.7% of flowResMed Common StockSEC:0001127602-25-008593:0
2,000 shares@ US$242.115.2% of flowResMed Common StockSEC:0001127602-25-003232:0
2,000 shares@ US$230.994.9% of flowResMed Common StockSEC:0001127602-25-000487:0
2,000 shares@ US$245.655.2% of flowResMed Common StockSEC:0001127602-24-028741:0
542 shares0ResMed Common StockSEC:0001127602-24-027893:0
527.905 shares@ US$252.381.4% of flowResMed Common StockSEC:0001127602-24-027102:0
2,000 shares@ US$248.745.0% of flowResMed Common StockSEC:0001127602-24-026799:0
2,000 shares@ US$237.204.8% of flowResMed Common StockSEC:0001127602-24-024898:0
2,000 shares@ US$239.904.8% of flowResMed Common StockSEC:0001127602-24-023609:0
3,131 shares0Common StockSEC:0001193805-24-000824:0
68,200 shares0ResMed Common StockSEC:0001127602-24-015779:0
12,600 shares@ US$237.172629.9% of flowResMed Common StockSEC:0001127602-24-006731:0
1,768 shares0ResMed Common StockSEC:0001127602-23-028045:0
325.375 shares@ US$143.600.5% of flowResMed Common StockSEC:0001127602-23-027459:0
8,293 shares0Common StockSEC:0001570562-23-000020:0
1,122 shares0ResMed Common StockSEC:0001127602-22-026046:0
128 shares@ US$225.180.3% of flowResMed Common StockSEC:0001127602-22-025653:0
9,050 shares@ US$221.975422.4% of flowResMed Common StockSEC:0001127602-22-024789:0
10,000 shares@ US$9.1048100.0% of flowCommon StockSEC:0001570562-22-000127:0
Ideal exit: 3 Jun 2023 (T+270)
15,568 shares0Common StockSEC:0001570562-22-000048:0
15,568 shares0Common StockSEC:0001570562-22-000048
478 shares0ResMed Common StockSEC:0000943819-21-000037:0
478 shares0ResMed Common StockSEC:0000943819-21-000037
25 of 33 declarations
About FARRELL PETER C
Peter C. Farrell is a Director at ResMed Inc and Evolus, Inc. He contributes to the governance of these companies by providing his expertise and advice to the board of directors. His role involves overseeing operations and ensuring that decisions made are in the best interest of shareholders.
